1258428-05-5

1258428-05-5 structure

Name: Macitentan D4
Chemical Name: N-[5-(4-Bromophenyl)-6-({2-[(5-bromo-2-pyrimidinyl)oxy](2H4)ethyl}oxy)-4-pyrimidinyl]-N'-propylsulfuric diamide
CAS Number: 1258428-05-5
Molecular Formula: C₁₉H₁₆D₄Br₂N₆O₄S
Molecular Weight: 592.29800
Catalog: Signaling Pathways Apoptosis Apoptosis
Create Date: 2017-02-04 20:20:00
Modify Date: 2024-01-10 04:51:36
Macitentan D4 (ACT-064992 D4) is a deuterium labeled Sulfamethoxazole. Macitentan is an orally active, non-peptide dual ETA and ETB (endothelin) receptor antagonist. Macitentan is used for the potential treatment of idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension (PAH)[1].

Name	N-[5-(4-Bromophenyl)-6-({2-[(5-bromo-2-pyrimidinyl)oxy](2H4)ethyl}oxy)-4-pyrimidinyl]-N'-propylsulfuric diamide
Synonyms	N-[5-(4-Bromophenyl)-6-({2-[(5-bromo-2-pyrimidinyl)oxy](H)ethyl}oxy)-4-pyrimidinyl]-N'-propylsulfuric diamide Sulfamide, N-[5-(4-bromophenyl)-6-[[2-[(5-bromo-2-pyrimidinyl)oxy]ethyl-1,1,2,2-d]oxy]-4-pyrimidinyl]-N'-propyl-

Description	Macitentan D4 (ACT-064992 D4) is a deuterium labeled Sulfamethoxazole. Macitentan is an orally active, non-peptide dual ETA and ETB (endothelin) receptor antagonist. Macitentan is used for the potential treatment of idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension (PAH)[1].
Related Catalog	Signaling Pathways >> Apoptosis >> Apoptosis Research Areas >> Cardiovascular Disease Signaling Pathways >> GPCR/G Protein >> Endothelin Receptor
Target	ETA/ETB[1]
References	[1]. Corallo C, et al. Bosentan and macitentan prevent the endothelial-to-mesenchymal transition (EndoMT) in systemic sclerosis: in vitro study. Arthritis Res Ther. 2016 Oct 6;18(1):228.